Home › Funds › GENEVA CAPITAL MANAGEMENT LLC › VCEL

GENEVA CAPITAL MANAGEMENT LLC position in VCEL

VERICEL CORP · Health Care

GENEVA CAPITAL MANAGEMENT LLC reported holding 1,297,344 shares of VCEL (VERICEL CORP) in its Q3 2026 13F filing — a position valued at US$52.1M, representing 1.45% of its reported portfolio and ranking #22 among its reported holdings. GENEVA CAPITAL MANAGEMENT LLC has disclosed VCEL holdings in 13 of the last 13 reported quarters, going back to Q3 2023.

Latest position (Q3 2026)1.30M sh
Reported value held$52.08M
Portfolio Weight1.45%
First reportedQ3 2023
Last changeReduce
Updated2026-11-13

Last updated: 2026-11-13 · Source: SEC EDGAR Form 13F-HR

How GENEVA CAPITAL MANAGEMENT LLC's VCEL position evolved

GENEVA CAPITAL MANAGEMENT LLC first disclosed a stake in VCEL in Q3 2023 at 435,179 shares (US$14.6M). The position peaked in Q2 2025 at 1,784,927 shares, worth US$75.9M. Across 13 filings, GENEVA CAPITAL MANAGEMENT LLC increased the stake 7 time(s), trimmed it 4 time(s) and left it unchanged 1 time(s). The most recent filing (Q3 2026) shows 1,297,344 shares valued at US$52.1M — a reduction of -41,779 shares quarter over quarter.. Notable position changes include a 44% increase in Q1 2024 (shares fell 12% over the following quarter), a 61% increase in Q3 2024 (shares rose 30% over the following quarter), a 31% increase in Q2 2025 (shares fell 26% over the following quarter).

Quarter by quarter

QuarterSharesValueChange
Q3 2023 435.18K $14.59M New
Q4 2023 472.96K $16.84M Add
Q1 2024 679.16K $35.33M Add
Q2 2024 684.31K $31.40M Add
Q3 2024 1.10M $46.66M Add
Q4 2024 1.10M $60.39M Hold
Q1 2025 1.37M $60.94M Add
Q2 2025 1.78M $75.95M Add
Q3 2025 1.95M $61.25M Add
Q4 2025 1.83M $65.78M Reduce
Q1 2026 1.65M $52.98M Reduce
Q2 2026 1.34M $59.58M Reduce
Q3 2026 1.30M $52.08M Reduce

Dots on the line are colored by change type; missing quarters mean no position was reported.

About VCEL and 13F data

VCEL (VERICEL CORP) is a Health Care company. 27 other funds we track also report a position in VCEL — the largest reported positions include CONGRESS ASSET MANAGEMENT CO (US$102.4M), Soleus Capital Management, L.P. (US$64.9M), Conestoga Capital Advisors, LLC (US$63.1M). Under SEC rules, institutional investment managers with over $100M in assets must file Form 13F within 45 days of each quarter-end, disclosing long positions in US-listed equities. The data excludes short positions, most options and foreign holdings, so treat it as a quarterly snapshot rather than a live position.

Other funds holding VCEL

All VCEL fund holders →

FAQ

How long has GENEVA CAPITAL MANAGEMENT LLC held VCEL?

GENEVA CAPITAL MANAGEMENT LLC has disclosed VCEL holdings in 13 of the last 13 reported quarters, going back to Q3 2023.

What is GENEVA CAPITAL MANAGEMENT LLC's current position in VCEL?

As of Q3 2026, GENEVA CAPITAL MANAGEMENT LLC holds 1.30M shares of VCEL (VERICEL CORP), valued at $52.08M, representing 1.45% of its reported portfolio and ranking #22.

Has GENEVA CAPITAL MANAGEMENT LLC been buying or selling VCEL?

In the latest 13F filing (Q3 2026), GENEVA CAPITAL MANAGEMENT LLC reduced its position in VCEL. The position peaked in Q2 2025 at 1.78M shares.

Which other funds hold VCEL?

Other major institutional holders of VCEL include CONGRESS ASSET MANAGEMENT CO, Soleus Capital Management, L.P., Conestoga Capital Advisors, LLC, among 27 funds with disclosed positions.

Where does this data come from?

All figures are computed from SEC Form 13F quarterly filings, which institutional investment managers must file within 45 days of quarter end for long positions of $100,000 or more.